{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:04:09Z","timestamp":1790798649283,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":71,"publisher":"Springer US","isbn-type":[{"value":"9781071615065","type":"print"},{"value":"9781071615072","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-1507-2_15","type":"book-chapter","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T06:26:06Z","timestamp":1623219966000},"page":"215-227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Protein-Bound Uremic Toxins and Immunity"],"prefix":"10.1007","author":[{"given":"Maria Teresa","family":"Rocchetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Cosola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ranieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,31]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-3083.1976.tb02997.x","volume":"5","author":"AA Birkeland","year":"1976","unstructured":"Birkeland AA (1976) Uremia as a state of immune deficiency. Scand J Immunol 5:107","journal-title":"Scand J Immunol"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000330673","volume":"34","author":"HE Wang","year":"2011","unstructured":"Wang HE, Gamboa C, Warnock DG et al (2011) Chronic kidney disease and risk of death from infection. Am J Nephrol 34:330\u2013336","journal-title":"Am J Nephrol"},{"issue":"5","key":"15_CR3","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2215\/CJN.00950208","volume":"3","author":"S Kato","year":"2008","unstructured":"Kato S, Chmielewski M, Honda H et al (2008) Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3(5):1526\u20131533. https:\/\/doi.org\/10.2215\/CJN.00950208","journal-title":"Clin J Am Soc Nephrol"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1056\/NEJM200008033430506","volume":"343","author":"RJCJ Medzhitov","year":"2000","unstructured":"Medzhitov RJCJ (2000) Innate immunity. N Engl J Med 343:338\u2013344","journal-title":"N Engl J Med"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.micinf.2004.08.018","volume":"6","author":"CMR Pasare","year":"2004","unstructured":"Pasare CMR (2004) Toll-like receptors: linking innate and adaptive immunity. Microbes Infect 6:1382\u20131387","journal-title":"Microbes Infect"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1056\/NEJM200007063430107","volume":"343","author":"PJRI Delves","year":"2000","unstructured":"Delves PJRI (2000) The immune system: first of two parts. N Engl J Med 343:37\u201349","journal-title":"N Engl J Med"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02786473","volume":"19","author":"JM Slavik","year":"1999","unstructured":"Slavik JM, Hutchcroft JEBB (1999) CD28\/CTLA-4 and CD80\/CD86 families: signaling and function. Immunol Res 19:1\u201324","journal-title":"Immunol Res"},{"key":"15_CR8","doi-asserted-by":"publisher","unstructured":"Cosola C, Rocchetti MT, Cupisti A et al (2018) Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease. Pharmacol Res:130. https:\/\/doi.org\/10.1016\/j.phrs.2018.03.003","DOI":"10.1016\/j.phrs.2018.03.003"},{"key":"15_CR9","doi-asserted-by":"publisher","unstructured":"Cosola C, Rocchetti MT, Sabatino A et al (2019) Microbiota issue in CKD: how promising are gut-targeted approaches? J Nephrol 32(1). https:\/\/doi.org\/10.1007\/s40620-018-0516-0","DOI":"10.1007\/s40620-018-0516-0"},{"issue":"5","key":"15_CR10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/ndt\/gfv095","volume":"31","author":"ND Vaziri","year":"2016","unstructured":"Vaziri ND, Zhao YY, Pahl MV (2016) Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: The nature, mechanisms, consequences and potential treatment. Nephrol Dial Transplant 31(5):737\u2013746. https:\/\/doi.org\/10.1093\/ndt\/gfv095","journal-title":"Nephrol Dial Transplant"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.niox.2016.05.002","volume":"57","author":"D Briskey","year":"2016","unstructured":"Briskey D, Tucker PS, Johnson DW et al (2016) Microbiota and the nitrogen cycle: Implications in the development and progression of CVD and CKD. Nitric Oxide 57:64\u201370. https:\/\/doi.org\/10.1016\/j.niox.2016.05.002","journal-title":"Nitric Oxide"},{"issue":"19","key":"15_CR12","first-page":"2918","volume":"18","author":"M Liu","year":"2014","unstructured":"Liu M, Li XC, Lu L et al (2014) Cardiovascular disease and its relationship with chronic kidney disease. Eur Rev Med Pharmacol Sci 18(19):2918\u20132926","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"15_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2174\/1871526511313030008","volume":"13","author":"VYM Gupta","year":"2013","unstructured":"Gupta VYM (2013) Infection and hemodialysis access: an updated review. Infect Disord Drug Targets 13(3):196\u2013205","journal-title":"Infect Disord Drug Targets"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/sj.ki.5002744","volume":"73","author":"GH Heine","year":"2008","unstructured":"Heine GH, Ulrich C, Seibert E et al (2008) CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int 73:622\u2013629. https:\/\/doi.org\/10.1038\/sj.ki.5002744","journal-title":"Kidney Int"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nrneph.2012.41","volume":"8","author":"GH Heine","year":"2012","unstructured":"Heine GH, Ortiz A, Massy ZA et al (2012) Monocyte subpopulations and cardiovascular risk in chronic kidney disease. Nat Rev Nephrol 8:362\u2013369. https:\/\/doi.org\/10.1038\/nrneph.2012.41","journal-title":"Nat Rev Nephrol"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/j.1523-1755.2005.00200.x","volume":"67","author":"P Stenvinkel","year":"2005","unstructured":"Stenvinkel P, Ketteler M, Johnson RJ et al (2005) IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia\u2013the good, the bad, and the ugly. Kidney Int 67:1216\u20131233","journal-title":"Kidney Int"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1681\/ASN.V131204","volume":"13","author":"P Meier","year":"2002","unstructured":"Meier P, Dayer E, Blanc EWJ (2002) Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol 13:204\u2013212","journal-title":"J Am Soc Nephrol"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0006-291X(03)01389-5","volume":"308","author":"B Moser","year":"2003","unstructured":"Moser B, Roth G, Brunner M et al (2003) Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis. Biochem Biophys Res Commun 308:581\u2013585","journal-title":"Biochem Biophys Res Commun"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/sj.ki.5001550","volume":"70","author":"J Yoon","year":"2006","unstructured":"Yoon J, Gollapudi S, Pahl MVN (2006) Na\u00efve and central memory T-cell lymphopenia in endstage renal disease. Kidney Int 70:371\u2013376","journal-title":"Kidney Int"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1093\/ndt\/gfi048","volume":"20","author":"M Ando","year":"2005","unstructured":"Ando M, Shibuya A, Yasuda M et al (2005) Impairment of innate cellular response to in vitro stimuli in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transpl 20:2497\u20132503","journal-title":"Nephrol Dial Transpl"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1093\/ndt\/15.8.1217","volume":"15","author":"U Sester","year":"2000","unstructured":"Sester U, Sester M, Hauk M et al (2000) T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transpl 15:1217\u20131223","journal-title":"Nephrol Dial Transpl"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/ndt\/15.4.502","volume":"15","author":"G Fernandez-Fresnedo","year":"2000","unstructured":"Fernandez-Fresnedo G, Ramos MAG-PM, de Francisco AL et al (2000) B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transpl 15:502\u2013510","journal-title":"Nephrol Dial Transpl"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1525-139X.2007.00283.x","volume":"20","author":"T Eleftheriadis","year":"2007","unstructured":"Eleftheriadis T, Antoniadi G, Liakopoulos V et al (2007) Disturbances of acquired immunity in hemodialysis patients. Semin Dial 20:440\u2013451","journal-title":"Semin Dial"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/ki.2008.301","volume":"74","author":"MG Betjes","year":"2008","unstructured":"Betjes MG, Huisman M, Weimar W et al (2008) Expansion of cytolytic CD4+ CD28- T cells in end-stage renal diseases. Kidney Int 74:760\u2013767","journal-title":"Kidney Int"},{"issue":"9","key":"15_CR25","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/jcm8091424","volume":"8","author":"BR Di Iorio","year":"2019","unstructured":"Di Iorio BR, Rocchetti MT, De Angelis M et al (2019) Nutritional therapy modulates intestinal microbiota and reduces serum levels of total and free Indoxyl sulfate and P-Cresyl sulfate in chronic kidney disease (Medika study). J Clin Med 8(9):1424. https:\/\/doi.org\/10.3390\/jcm8091424","journal-title":"J Clin Med"},{"issue":"4","key":"15_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF02082475","volume":"12","author":"K K\u00e1lm\u00e1n","year":"1980","unstructured":"K\u00e1lm\u00e1n K, L\u0151csey L, Hauck M et al (1980) The effect of uraemic \u201cmiddle-sized molecules\u201d on T lymphocyte functions. Int Urol Nephrol 12(4):367\u2013374. https:\/\/doi.org\/10.1007\/BF02082475","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"15_CR27","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/ndt\/gfp592","volume":"25","author":"S Liabeuf","year":"2010","unstructured":"Liabeuf S, Barreto DV, Barreto FC et al (2010) Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant 25(4):1183\u20131191. https:\/\/doi.org\/10.1093\/ndt\/gfp592","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"15_CR28","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/ndt\/gfq580","volume":"26","author":"IW Wu","year":"2011","unstructured":"Wu IW, Hsu KH, Lee CC et al (2011) P-cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol Dial Transplant 26(3):938\u2013947. https:\/\/doi.org\/10.1093\/ndt\/gfq580","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"15_CR29","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/ndt\/gfr453","volume":"27","author":"IW Wu","year":"2012","unstructured":"Wu IW, Hsu KH, Hsu HJ et al (2012) Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients: a prospective cohort study. Nephrol Dial Transplant 27(3):1169\u20131175. https:\/\/doi.org\/10.1093\/ndt\/gfr453","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"15_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2215\/CJN.05340610","volume":"6","author":"M Yu","year":"2011","unstructured":"Yu M, Kim YJ, Kang D-H et al (2011) Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress. Clin J Am Soc Nephrol 6(1):30\u201339. https:\/\/doi.org\/10.2215\/CJN.05340610","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"15_CR31","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00216-012-5929-3","volume":"403","author":"Y Itoh","year":"2012","unstructured":"Itoh Y, Ezawa A, Kikuchi K et al (2012) Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography\/tandem mass spectrometry and their effects on endothelial ROS production. Anal Bioanal Chem 403(7):1841\u20131850. https:\/\/doi.org\/10.1007\/s00216-012-5929-3","journal-title":"Anal Bioanal Chem"},{"issue":"9","key":"15_CR32","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/toxins10090352","volume":"10","author":"S Lekawanvijit","year":"2018","unstructured":"Lekawanvijit S (2018) Cardiotoxicity of uremic toxins: a driver of cardiorenal syndrome. Toxins (Basel) 10(9):352. https:\/\/doi.org\/10.3390\/toxins10090352","journal-title":"Toxins (Basel)"},{"issue":"9","key":"15_CR33","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1681\/ASN.2013101062","volume":"25","author":"R Vanholder","year":"2014","unstructured":"Vanholder R, Schepers E, Pletinck A et al (2014) The uremic toxicity of indoxyl sulfate and p-Cresyl sulfate: a systematic review. J Am Soc Nephrol 25(9):1897\u20131907. https:\/\/doi.org\/10.1681\/ASN.2013101062","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"15_CR34","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1523-1755.2004.00399.x","volume":"65","author":"L Dou","year":"2004","unstructured":"Dou L, Bertrand E, Cerini C et al (2004) The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 65(2):442\u2013451. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00399.x","journal-title":"Kidney Int"},{"issue":"1","key":"15_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2369-14-56","volume":"14","author":"D Bolati","year":"2013","unstructured":"Bolati D, Shimizu H, Yisireyili M et al (2013) Indoxyl sulfate , a uremic toxin , downregulates renal expression of Nrf2 through activation of NF- \u03ba B. BMC Nephrol 14(1):1. https:\/\/doi.org\/10.1186\/1471-2369-14-56","journal-title":"BMC Nephrol"},{"issue":"24\u201326","key":"15_CR36","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.lfs.2013.05.008","volume":"92","author":"M Yisireyili","year":"2013","unstructured":"Yisireyili M, Shimizu H, Saito S et al (2013) Indoxyl sulfate promotes cardiac fi brosis with enhanced oxidative stress in hypertensive rats. Life Sci 92(24\u201326):1180\u20131185. https:\/\/doi.org\/10.1016\/j.lfs.2013.05.008","journal-title":"Life Sci"},{"key":"15_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.5414\/CNP60161","volume":"60","author":"A Kato","year":"2003","unstructured":"Kato A, Odamaki M, Hishida A (2003) Association between blood indoxyl sulfate and carbonyl stress marker in hemodialysis patients. Clin Nephrol 60:161\u2013167","journal-title":"Clin Nephrol"},{"issue":"14","key":"15_CR38","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/eurheartj\/ehp574","volume":"31","author":"S Lekawanvijit","year":"2010","unstructured":"Lekawanvijit S, Adrahtas A, Kelly DJ et al (2010) Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? Eur Hear J 31(14):1771\u20131779. https:\/\/doi.org\/10.1093\/eurheartj\/ehp574","journal-title":"Eur Hear J"},{"issue":"10","key":"15_CR39","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1681\/ASN.2014060543","volume":"26","author":"K Yang","year":"2015","unstructured":"Yang K, Wang C, Nie L et al (2015) Klotho protects against indoxyl sulphate-induced myocardial hypertrophy. J Am Soc Nephrol 26(10):2434\u20132446. https:\/\/doi.org\/10.1681\/ASN.2014060543","journal-title":"J Am Soc Nephrol"},{"key":"15_CR40","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/j.1538-7836.2007.02540.x","volume":"33","author":"L Dou","year":"2007","unstructured":"Dou L, Faure V, Cerini C et al (2007) The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J Thromb Haemost 33:1302\u20131308","journal-title":"J Thromb Haemost"},{"issue":"13\u201314","key":"15_CR41","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.lfs.2012.01.013","volume":"90","author":"H Shimizu","year":"2012","unstructured":"Shimizu H, Bolati D, Higashiyama Y et al (2012) Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF- \u03ba B , p53 , ERK , and JNK in proximal tubular cells. Life Sci 90(13\u201314):525\u2013530. https:\/\/doi.org\/10.1016\/j.lfs.2012.01.013","journal-title":"Life Sci"},{"issue":"1","key":"15_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/ndt\/gfs133","volume":"28","author":"CY Sun","year":"2013","unstructured":"Sun CY, Hsu HH, Wu MS (2013) P-Cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cells. Nephrol Dial Transplant 28(1):70\u201378. https:\/\/doi.org\/10.1093\/ndt\/gfs133","journal-title":"Nephrol Dial Transplant"},{"key":"15_CR43","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00398.x","volume":"68","author":"M Tonelli","year":"2005","unstructured":"Tonelli M, Sacks F, Pfeffer M et al (2005) Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68:237\u2013245. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00398.x","journal-title":"Kidney Int"},{"key":"15_CR44","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1038\/ki.2010.418","volume":"119","author":"SBKR Lee","year":"2010","unstructured":"Lee SBKR (2010) Mechanistic connection between inflammation and fibrosis. Kidney Int Suppl 119:S22\u2013S26","journal-title":"Kidney Int Suppl"},{"key":"15_CR45","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1159\/000299798","volume":"31","author":"Z Tumur","year":"2010","unstructured":"Tumur Z, Shimizu H, Enomoto A et al (2010) Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-\u03baB activation. Am J Nephrol 31:435\u2013441. https:\/\/doi.org\/10.1159\/000299798","journal-title":"Am J Nephrol"},{"issue":"50","key":"15_CR46","doi-asserted-by":"publisher","first-page":"38869","DOI":"10.1074\/jbc.M110.166686","volume":"285","author":"S Ito","year":"2010","unstructured":"Ito S, Osaka M, Higuchi Y et al (2010) Indoxyl Sulfate Induces Leukocyte-Endothelial Interactions through Up-regulation of E-selectin. J Biol Chem 285(50):38869\u201338875. https:\/\/doi.org\/10.1074\/jbc.M110.166686","journal-title":"J Biol Chem"},{"key":"15_CR47","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/ndt\/gfl584","volume":"22","author":"E Schepers","year":"2007","unstructured":"Schepers E, Meert N, Glorieux G et al (2007) P-cresylsulphate, the main in vivo metabolite of p -cresol, activates leucocyte free radical production. Nephrol Dial Transplant 22:592\u2013596. https:\/\/doi.org\/10.1093\/ndt\/gfl584","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"15_CR48","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/ki.2011.445","volume":"81","author":"C Sun","year":"2012","unstructured":"Sun C, Chang S, Wu M (2012) Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney Int 81(7):640\u2013650. https:\/\/doi.org\/10.1038\/ki.2011.445","journal-title":"Kidney Int"},{"key":"15_CR49","doi-asserted-by":"publisher","first-page":"C685","DOI":"10.1152\/ajpcell.00236.2012","volume":"304","author":"H Shimizu","year":"2013","unstructured":"Shimizu H, Saito S, Higashiyama Y et al (2013) CREB, NF-kB, and NADPH oxi- dase coordinately upregulate indoxyl sul- fate-induced angiotensinogen expression in proximal tubular cells. Am J Physiol Cell Physiol 304:C685\u2013C692","journal-title":"Am J Physiol Cell Physiol"},{"key":"15_CR50","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1080\/08923970802680299","volume":"31","author":"K Kawakami","year":"2009","unstructured":"Kawakami K, Makino I, Kato I et al (2009) p-Cresol inhibits IL-12 production by murine macrophages stimulated with bacterial immunostimulant. Immunopharmacol Immunotoxicol 31:304\u2013309","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"6","key":"15_CR51","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1159\/000345146","volume":"36","author":"L Viaene","year":"2012","unstructured":"Viaene L, Evenepoel P, Meijers B et al (2012) Uremia suppresses immune signal-induced CYP27B1 expression in human monocytes. Am J Nephrol 36(6):497\u2013508. https:\/\/doi.org\/10.1159\/000345146","journal-title":"Am J Nephrol"},{"issue":"2","key":"15_CR52","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.taap.2013.10.016","volume":"274","author":"T Shiba","year":"2014","unstructured":"Shiba T, Kawakami K, Sasaki T et al (2014) Effects of intestinal bacteria-derived p-cresyl sulfate on Th1-type immune response in vivo and in vitro. Toxicol Appl Pharmacol 274(2):191\u2013199. https:\/\/doi.org\/10.1016\/j.taap.2013.10.016","journal-title":"Toxicol Appl Pharmacol"},{"key":"15_CR53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.toxlet.2016.01.009","volume":"245","author":"T Shiba","year":"2016","unstructured":"Shiba T, Makino I, Kawakami K et al (2016) p-Cresyl sulfate suppresses lipopolysaccharide-induced anti-bacterial immune responses in murine macrophages in vitro. Toxicol Lett 245:24\u201330. https:\/\/doi.org\/10.1016\/j.toxlet.2016.01.009","journal-title":"Toxicol Lett"},{"key":"15_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2016.10.006","volume":"263","author":"A MLV","year":"2016","unstructured":"MLV A, Bonan NB, Dias G et al (2016) p-Cresyl sulfate affects the oxidative burst, phagocytosis process, and antigen presentation of monocyte-derived macrophages. Toxicol Lett 263:1\u20135. https:\/\/doi.org\/10.1016\/j.toxlet.2016.10.006","journal-title":"Toxicol Lett"},{"key":"15_CR55","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.taap.2018.01.025","volume":"342","author":"T Shiba","year":"2018","unstructured":"Shiba T, Makino I, Sasaki T et al (2018) p-Cresyl sulfate decreases peripheral B cells in mice with adenine-induced renal dysfunction. Toxicol Appl Pharmacol 342:50\u201359. https:\/\/doi.org\/10.1016\/j.taap.2018.01.025","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"15_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-03130-z","volume":"7","author":"HY Kim","year":"2017","unstructured":"Kim HY, Yoo TH, Hwang Y et al (2017) Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD). Sci Rep 7(1):1\u201316. https:\/\/doi.org\/10.1038\/s41598-017-03130-z","journal-title":"Sci Rep"},{"key":"15_CR57","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/eurheartj\/ehq371","volume":"32","author":"KS Rogacev","year":"2011","unstructured":"Rogacev KS et al (2011) CD14++ CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur Hear J 32:84\u201392. https:\/\/doi.org\/10.1093\/eurheartj\/ehq371","journal-title":"Eur Hear J"},{"key":"15_CR58","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00008571-199310000-00001","volume":"3","author":"HI Swanson","year":"1993","unstructured":"Swanson HI, Bradfield CA (1993) The AH-receptor: genetics, structure and function. Pharmacogenetics 3:213\u2013230","journal-title":"Pharmacogenetics"},{"key":"15_CR59","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1016\/j.febslet.2007.03.046","volume":"581","author":"R Barouki","year":"2007","unstructured":"Barouki R, Coumoul X, Fernandez-Salguero PM (2007) The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett 581:3608\u20133615","journal-title":"FEBS Lett"},{"issue":"6","key":"15_CR60","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1189\/jlb.0112023","volume":"93","author":"S Ito","year":"2013","unstructured":"Ito S, Higuchi Y, Yagi Y et al (2013) Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease. J Leukoc Biol 93(6):837\u2013845. https:\/\/doi.org\/10.1189\/jlb.0112023","journal-title":"J Leukoc Biol"},{"key":"15_CR61","doi-asserted-by":"publisher","unstructured":"Adesso S, Popolo A, Bianco , et al (2013) The uremic toxin indoxyl sulphate enhances macrophage response to LPS. PLoS One 8(9). https:\/\/doi.org\/10.1371\/journal.pone.0076778","DOI":"10.1371\/journal.pone.0076778"},{"issue":"2","key":"15_CR62","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.toxlet.2013.04.016","volume":"220","author":"SJ Hwang","year":"2013","unstructured":"Hwang SJ, Hwang YJ, Yun MO et al (2013) Indoxyl 3-sulfate stimulates Th17 differentiation enhancing phosphorylation of c-Src and STAT3 to worsen experimental autoimmune encephalomyelitis. Toxicol Lett 220(2):109\u2013117. https:\/\/doi.org\/10.1016\/j.toxlet.2013.04.016","journal-title":"Toxicol Lett"},{"issue":"1","key":"15_CR63","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.toxlet.2013.11.027","volume":"225","author":"YJ Hwang","year":"2014","unstructured":"Hwang YJ, Yun MO, Jeong KT et al (2014) Uremic toxin indoxyl 3-sulfate regulates the differentiation of Th2 but not of Th1 cells to lessen allergic asthma. Toxicol Lett 225(1):130\u2013138. https:\/\/doi.org\/10.1016\/j.toxlet.2013.11.027","journal-title":"Toxicol Lett"},{"issue":"5","key":"15_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4110\/in.2018.18.e35","volume":"18","author":"WB Hwang","year":"2018","unstructured":"Hwang WB, Kim DJ, Oh GS et al (2018) Aryl hydrocarbon receptor ligands indoxyl 3-sulfate and indole-3-carbinol inhibit fms-like tyrosine kinase 3 ligand-induced bone marrow-derived plasmacytoid dendritic cell differentiation. Immune Netw 18(5):1\u201316. https:\/\/doi.org\/10.4110\/in.2018.18.e35","journal-title":"Immune Netw"},{"issue":"11","key":"15_CR65","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1002\/eji.1830251103","volume":"25","author":"H Bour","year":"1995","unstructured":"Bour H, Peyron E, Gaucherand M et al (1995) Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur J Immunol 25(11):3006\u20133010. https:\/\/doi.org\/10.1002\/eji.1830251103","journal-title":"Eur J Immunol"},{"issue":"3","key":"15_CR66","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2174\/138920010791196300","volume":"11","author":"A Cavani","year":"2010","unstructured":"Cavani A, De Luca A (2010) Allergic Contact Dermatitis: Novel Mechanisms and Therapeutic Perspectives. Curr Drug Metab 11(3):228\u2013233. https:\/\/doi.org\/10.2174\/138920010791196300","journal-title":"Curr Drug Metab"},{"issue":"2","key":"15_CR67","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.imbio.2017.10.014","volume":"223","author":"S Ghimire","year":"2018","unstructured":"Ghimire S, Matos C, Caioni M et al (2018) Indoxyl 3-sulfate inhibits maturation and activation of human monocyte-derived dendritic cells. Immunobiology 223(2):239\u2013245. https:\/\/doi.org\/10.1016\/j.imbio.2017.10.014","journal-title":"Immunobiology"},{"key":"15_CR68","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev.pharmtox.43.100901.135828","volume":"43","author":"MSNS Denison","year":"2003","unstructured":"Denison MSNS (2003) Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43:309\u2013334","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"15_CR69","doi-asserted-by":"publisher","unstructured":"Heianza Y, Ma W, Manson E et al (2017) Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies. J Am Hear Assoc 6(7). https:\/\/doi.org\/10.1161\/JAHA.116.004947. pii: e004947","DOI":"10.1161\/JAHA.116.004947"},{"issue":"4","key":"15_CR70","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/ASN.2013121283","volume":"26","author":"L Dou","year":"2015","unstructured":"Dou L, Sallee M, Cerini C et al (2015) The cardiovascular effect of the uremic solute Indole-3 acetic acid. J Am Soc Nephrol 26(4):876\u2013887. https:\/\/doi.org\/10.1681\/ASN.2013121283","journal-title":"J Am Soc Nephrol"},{"key":"15_CR71","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/toxsci\/kfq024","volume":"115","author":"BC DiNatale","year":"2010","unstructured":"DiNatale BC, Murray IA, Schroeder JC et al (2010) Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin- 6 in the presence of inflammatory signaling. Toxicol Sci 115:89\u201397. https:\/\/doi.org\/10.1093\/toxsci\/kfq024","journal-title":"Toxicol Sci"}],"container-title":["Methods in Molecular Biology","Cytotoxic T-Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1507-2_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T06:27:22Z","timestamp":1623220042000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1507-2_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9781071615065","9781071615072"],"references-count":71,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1507-2_15","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"31 May 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}